文献速递消化道肿瘤与早癌

非编码RNA在消化道肿瘤中:从癌症标志到临床应用

Non-coding RNAs in GI cancers: from cancer hallmarks to clinical utility.
PubMed 文献 · Gut · 2020-02-07

本文综述了microRNA、长链非编码RNA和环状RNA在消化道肿瘤中的生物学功能与转化价值,指出非编码RNA可调控癌症标志、参与细胞间通讯并作为体液生物标志物,其治疗靶向策略正在开发中。

要点

  • 非编码RNA通过调控癌症标志参与消化道肿瘤发生发展。
  • 非编码RNA是体液生物标志物鉴定的主流方向。
  • 靶向非编码RNA的治疗策略目前仍在开发中。

核心结论

  • 非编码RNA在消化道肿瘤中调控癌症标志,具有生物标志物和治療靶点的转化潜力。

研究设计与样本

  • 综述,聚焦microRNA、长链非编码RNA和环状RNA三类非编码RNA。

主要发现

  • 非编码RNA与多种遗传元件相互作用,最终调控癌症标志。
  • 非编码RNA是丰富的激素类型,参与细胞间通讯和肿瘤微环境互作。
  • 体液非编码RNA谱分析成为生物标志物鉴定的主流。
  • 靶向非编码RNA的治疗策略正在开发中。

临床怎么用

  • 可关注体液非编码RNA谱作为消化道肿瘤生物标志物的潜力。
  • 靶向非编码RNA的治疗策略尚待临床验证。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

One of the most unexpected discoveries in molecular oncology, in the last decades, was the identification of a new layer of protein coding gene regulation by transcripts that do not codify for proteins, the non-coding RNAs. These represent a heterogeneous category of transcripts that interact with many types of genetic elements, including regulatory DNAs, coding and other non-coding transcripts and directly to proteins. The final outcome, in the malignant context, is the regulation of any of the cancer hallmarks. Non-coding RNAs represent the most abundant type of hormones that contribute significantly to cell-to cell communication, revealing a complex interplay between tumour cells, tumour microenvironment cells and immune cells. Consequently, profiling their abundance in bodily fluids became a mainstream of biomarker identification. Therapeutic targeting of non-coding RNAs represents a new option for clinicians that is currently under development. This review will present the biology and translational value of three of the most studied categories on non-coding RNAs, the microRNAs, the long non-coding RNAs and the circular RNAs. We will also focus on some aspirational concepts that can help in the development of clinical applications related to non-coding RNAs, including using pyknons to discover new non-coding RNAs, targeting human-specific transcripts which are expressed specifically in the tumour cell and using non-coding RNAs to increase the efficiency of immunotherapy.

来源:Gut,查看原文。版权归原作者所有。

引用

  1. Dragomir MP, Kopetz S, Ajani JA, et al. Non-coding RNAs in GI cancers: from cancer hallmarks to clinical utility. Gut. 2020. PMID: 32034004. doi:10.1136/gutjnl-2019-318279

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。